Semi-annual Report for 2026

Earlier from Biocytogen Pharmaceuticals (Beijing)

• Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026Aug 7
• Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against HarbourJun 29
• Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Jun 26
• Indicative Announcement on Equity Change of Actual Controllers and Persons Acting in Concert Reaching 1% ScaleJun 17
• Announcement on Resolutions of the 18th Meeting of the 2nd Board of DirectorsJun 5

Later from Biocytogen Pharmaceuticals (Beijing)

• Announcement on Convening the 2026 Semi-annual Performance BriefingSep 2
• Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026Sep 17
• (688796)"BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD."Announcement on Convening the Q3 2026 Performance BriefingOct 30
• (688796)"BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD."Report for Q3 2026Oct 30